SUCCESS RATES FOR NEW DRUGS ENTERING CLINICAL-TESTING IN THE UNITED-STATES

被引：133

作者：

DIMASI, JA

机构：

[1] Center for the Study of Drug Development, Tufts University. Boston, MA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1995年 / 58卷 / 01期

关键词：

D O I：

10.1016/0009-9236(95)90066-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

收藏

页码：1 / 14

页数：14

相关论文

共 21 条

[1] Adams Walter, 1986, BIGNESS COMPLEX
[2] Baldwin W., 1987, MARKET STRUCTURE TEC
[3] BIOPHARMACEUTICALS AND CONVENTIONAL DRUGS - CLINICAL SUCCESS RATES
BIENZTADMOR, B
DICERBO, PA
TADMOR, G
LASAGNA, L
[J]. BIO-TECHNOLOGY, 1992, 10 (05): : 521 - 525
[4] COX C, 1978, UNPUB TECHNOLOGICAL
[5] Cox D R, 1984, ANAL SURVIVAL DATA
[6] RESEARCH-AND-DEVELOPMENT COSTS FOR NEW DRUGS BY THERAPEUTIC CATEGORY - A STUDY OF THE UNITED-STATES PHARMACEUTICAL-INDUSTRY
DIMASI, JA
HANSEN, RW
GRABOWSKI, HG
LASAGNA, L
[J]. PHARMACOECONOMICS, 1995, 7 (02) : 152 - 169
[7] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1992
DIMASI, JA
SEIBRING, MA
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (06) : 609 - 622
[8] COST OF INNOVATION IN THE PHARMACEUTICAL-INDUSTRY
DIMASI, JA
HANSEN, RW
GRABOWSKI, HG
LASAGNA, L
[J]. JOURNAL OF HEALTH ECONOMICS, 1991, 10 (02) : 107 - 142
[9] NEW DRUG DEVELOPMENT IN THE UNITED-STATES FROM 1963 TO 1990
DIMASI, JA
BRYANT, NR
LASAGNA, L
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) : 471 - 486
[10] COMPOSITION OF R-AND-D EXPENDITURES - RELATIONSHIP TO SIZE OF FIRM, CONCENTRATION, AND INNOVATIVE OUTPUT
MANSFIELD, E
[J]. REVIEW OF ECONOMICS AND STATISTICS, 1981, 63 (04) : 610 - 615